The RAS-MAPK signaling pathway is a crucial cellular communication pathway that regulates cell growth, differentiation, and survival. Known for its involvement in cell cycle control, this pathway is often dysregulated in cancer and other diseases. This intricate cascade, involving RAS proteins, RAF kinases, MEK, and MAPK (ERK), transmits signals from surface receptors to the nucleus, impacting gene expression and cell function.
AnyGenes qPCR arrays provide researchers with a comprehensive toolset for investigating the RAS-MAPK pathway. By enabling precise detection of key gene expression changes, AnyGenes products offer a reliable resource for studying cellular signaling dynamics and the impact of therapeutic interventions on RAS-MAPK-driven pathways.
The MAPK cascade. Once a ligand binds the tyrosine kinase receptor, it self-phosphorylates [18]. This creates binding sites for Shc and Shp2. GRB2 can associate with either and then recruit SOS [19,20]. SOS is a guanine exchange factor for Ras and induces the exchange of GDP for GTP [21]. Now active Ras will dimerize and bind Raf [21]. After activating Raf, GTPase activating proteins (GAP) will hydrolyze the GTP to GDP to return Ras to its resting inactive state [22]. The active Raf dimers will recruit MEK [23], which then activates ERK [3]. ERK interacts with Importin 7 at the nuclear envelope to facilitate its entry through the nuclear pore complex into the nucleus [24,25]. Once inside, it phosphorylates multiple transcription factors to alter gene expression in the cell and induce proliferation and survival [26].
The RAS-MAPK pathway relies on several key proteins that interact to ensure accurate signal transduction.
The RAS-MAPK pathway plays a vital role in several physiological processes:
RAS-MAPK pathway is initiated when a ligand binds to an RTK, leading to receptor dimerization and autophosphorylation. This creates docking sites for adaptor proteins like GRB2, which recruit GEFs such as SOS1. These GEFs facilitate the exchange of GDP for GTP on RAS, activating it. Activated RAS then interacts with RAF kinases at the plasma membrane, promoting a series of phosphorylation events that propagate the signal through MEK to ERK.
Alterations in the RAS-MAPK pathway are commonly observed in cancer, as well as in neurological and developmental disorders known as RASopathies. Mutations can lead to uncontrolled cell proliferation, resistance to apoptosis, and enhanced survival, which are hallmarks of malignancy. For instance, BRAF mutations are frequently found in melanoma and thyroid cancers. Therapeutic targeting of this pathway, especially at the level of MEK and BRAF, has shown promise in treating specific cancers, although resistance mechanisms often emerge.
Customize your own signaling pathways (SignArrays®) with the factors of your choice!
Simply download and complete our Personalized SignArrays® information file
and send it at
contact@anygenes.com
to get started on your project.